Madrid genetic diagnostics company offering prenatal screening and genomic testing for healthcare professionals.
Founded in 2008 and based in Madrid, Spain, NIMGenetics Genomica Y Medicina, S.L. provides clinical genetic diagnostics, including the TrisoNIM non-invasive prenatal test, plus genetic panels and exome sequencing for oncology, neurology and ophthalmology. Its customers include hospitals and laboratories in Spain, Portugal and Mexico, with partners in Europe, Latin America and the United States. In September 2021 Apposite Capital invested EUR 7.000 mn in a Growth round, and Carlos Catalan is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at NIMGenetics Genomica Y Medicina, S.L.? This is my company